BE1014089A4 - Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. - Google Patents
Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. Download PDFInfo
- Publication number
- BE1014089A4 BE1014089A4 BE2001/0104A BE200100104A BE1014089A4 BE 1014089 A4 BE1014089 A4 BE 1014089A4 BE 2001/0104 A BE2001/0104 A BE 2001/0104A BE 200100104 A BE200100104 A BE 200100104A BE 1014089 A4 BE1014089 A4 BE 1014089A4
- Authority
- BE
- Belgium
- Prior art keywords
- nucleic acid
- mpts
- activity
- metalloprotease
- antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne de nouvelles métalloprotéases possédant un ou des domaines thromboqpodine (protéines MPTS) et des polypeptides qui leur sont liés, ainsi que des compositions d'acides nucléiques codant pour ces protéines. les compositions de polypeptides et d'acides nucléiques de l'invention trouvent une utilisation dans toutes sortes d'applications, notamment des applications disgnostiques, des applications de sélection d'agents thérapeutiques, ainsi que des applications thérapeutiques pour toutes sortes de maladies différentes. L'invention a également trait à des procédés pour traiter des maladies associées à l'activité agrécanase, par exemple des pathologies caractérisées par la présence de produits de clivage de l'agrécane, telles que la polyarthrite rhumatoïde et l'arthose.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18415200P | 2000-02-18 | 2000-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE1014089A4 true BE1014089A4 (fr) | 2003-04-01 |
Family
ID=22675774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE2001/0104A BE1014089A4 (fr) | 2000-02-18 | 2001-02-15 | Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE1014089A4 (fr) |
| CA (1) | CA2332533A1 (fr) |
| IE (1) | IE20010121A1 (fr) |
| NL (2) | NL1017393C2 (fr) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999005291A2 (fr) * | 1997-07-25 | 1999-02-04 | Du Pont Pharmaceuticals Company | Metalloproteases decomposant l'aggrecan |
| WO2001042468A1 (fr) * | 1999-12-09 | 2001-06-14 | Lexicon Genetics Incorporated | Nouvelles protéases humaines et polynucléotides codant pour ces protéases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6391610B1 (en) * | 1999-08-06 | 2002-05-21 | The Cleveland Clinic Foundation | Nucleic acids encoding zinc metalloproteases |
| AU2002253883A1 (en) * | 2001-01-31 | 2002-08-12 | Incyte Genomics, Inc. | Protein modification and maintenance molecules |
-
2001
- 2001-02-14 IE IE20010121A patent/IE20010121A1/en not_active IP Right Cessation
- 2001-02-15 BE BE2001/0104A patent/BE1014089A4/fr not_active IP Right Cessation
- 2001-02-16 CA CA002332533A patent/CA2332533A1/fr not_active Abandoned
- 2001-02-19 NL NL1017393A patent/NL1017393C2/nl not_active IP Right Cessation
-
2002
- 2002-12-23 NL NL1022252A patent/NL1022252C2/nl not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999005291A2 (fr) * | 1997-07-25 | 1999-02-04 | Du Pont Pharmaceuticals Company | Metalloproteases decomposant l'aggrecan |
| WO2001042468A1 (fr) * | 1999-12-09 | 2001-06-14 | Lexicon Genetics Incorporated | Nouvelles protéases humaines et polynucléotides codant pour ces protéases |
Non-Patent Citations (1)
| Title |
|---|
| HURSKAINEN TIINA L ET AL: "ADAM-TS5, ADAM-TS6, and ADAM-TS7, novel members of a new family of zinc metalloproteases: General features and genomic distribution of the Adam-TS family", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 36, 3 September 1999 (1999-09-03), pages 25555 - 25563, XP002158991, ISSN: 0021-9258 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2332533A1 (fr) | 2001-08-18 |
| NL1017393C2 (nl) | 2003-01-09 |
| NL1022252A1 (nl) | 2003-01-23 |
| NL1022252C2 (nl) | 2003-11-18 |
| IE20010121A1 (en) | 2002-12-11 |
| NL1017393A1 (nl) | 2001-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chadani et al. | Escherichia coli YaeJ protein mediates a novel ribosome‐rescue pathway distinct from SsrA‐and ArfA‐mediated pathways | |
| Rodriguez et al. | Inducible degradation of IκBα in vitro and in vivo requires the acidic C-terminal domain of the protein | |
| Eyre et al. | Advances in collagen cross-link analysis | |
| Moore et al. | Ribosome rescue: tmRNA tagging activity and capacity in Escherichia coli | |
| Suppmann et al. | Dynamics and efficiency in vivo of UGA‐directed selenocysteine insertion at the ribosome | |
| RU2003112700A (ru) | Гены новых сериновых протеаз, родственных dppiv | |
| WO1996039429A3 (fr) | Proteine serique produite exclusivement dans les adipocytes | |
| Szklarczyk et al. | NDUFB7 and NDUFA8 are located at the intermembrane surface of complex I | |
| JP2005522999A5 (fr) | ||
| RU2218402C2 (ru) | Выделенный полипептид, имеющий гомологию относительно комплемент родственного белка адипоцитов (варианты), гибридный белок (варианты), экспрессирующий вектор, способ получения полипептида, поликлональное антитело, фрагмент выделенного полинуклеотида (варианты) | |
| Arsène et al. | Role of region C in regulation of the heat shock gene-specific sigma factor of Escherichia coli, ς32 | |
| Artemyev et al. | A site on transducin alpha-subunit of interaction with the polycationic region of cGMP phosphodiesterase inhibitory subunit. | |
| Szabova et al. | Expression pattern of four membrane‐type matrix metalloproteinases in the normal and diseased mouse mammary gland | |
| Ulrich et al. | Expression profile of proteins involved in scar formation in the healing process of full‐thickness excisional wounds in the porcine model | |
| Guenet et al. | Isolation of the leucine aminopeptidase gene from Aeromonas proteolytica. Evidence for an enzyme precursor. | |
| JP4378409B2 (ja) | グリシン輸送体 | |
| JPH10210982A5 (fr) | ||
| BE1014089A4 (fr) | Nouvelles metalloproteases possedant des domaines thrombospondine et compositions d'acides nucleiques les codant. | |
| NO972313D0 (no) | Peptider som er i stand til å binde til GAP-protein-SH3-området, nukleotid-sekvenser som koder for dette samt fremstilling og bruk derav | |
| Grainger et al. | Transcription activation at the Escherichia coli melAB promoter: interactions of MelR with the C‐terminal domain of the RNA polymerase α subunit | |
| JP2005525112A5 (fr) | ||
| WO2002008280A3 (fr) | Procedes de criblage bases sur l'integrine alpha v beta 3 superactivee | |
| WO2003070768A3 (fr) | Variants d'epissage cd40, compositions de fabrication et procedes d'utilisation de ceux-ci | |
| Hacques et al. | Accessibility and structural role of histone domains in chromatin. Biophysical and immunochemical studies of progressive digestion with immobilized proteases | |
| Obara et al. | A novel domain of fibronectin revealed by epitope mapping of a monoclonal antibody which inhibits fibroblasts‐mediated collagen gel contraction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Effective date: 20040228 |